Gerresheimer AG (GRRMY)
OTCMKTS · Delayed Price · Currency is USD
8.50
-2.71 (-24.17%)
Oct 13, 2025, 4:00 PM EDT
Gerresheimer AG Market Cap
Gerresheimer AG has a market cap or net worth of $1.15 billion as of October 14, 2025. Its market cap has decreased by -62.25% in one year.
Market Cap
1.15B
Enterprise Value
3.68B
Revenue
2.63B
Ranking
n/a
PE Ratio
41.96
Stock Price
$8.50
Market Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has decreased from 1.61B to 1.15B, a decrease of -28.76%. That is a compound annual growth rate of -1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 1.15B | -54.96% |
| Dec 30, 2024 | 2.54B | -29.36% |
| Dec 29, 2023 | 3.60B | 70.93% |
| Dec 30, 2022 | 2.11B | -30.02% |
| Dec 30, 2021 | 3.01B | -11.06% |
| Dec 30, 2020 | 3.39B | 39.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |